Infusion Therapy and Oncology

Selected news for the healthcare topic - Infusion Therapy, and the healthcare topic - Oncology. We have 21 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
9/3/2021 Fluid Renal Systems Market Global Industry Analysis and Forecast Till 2025 ... Infusion Therapy Systems: Urology Hospitals North America Renal Systems: Cardiology Clinics Europe Orthopedic/Osteology Dialysis Centers Asia Pacific Neurology Home Care Settings Latin America Oncology Others Middle East & Africa Gastroenterology Others (Anesthesiology, Bronchology, Dentistry, Otology and Gynecology) - Infusion Devices - IV Access Devices - IV Solutions & Products - In-center Hemodialysis Products - Home Hemodialysis Products (HHD) - Peritoneal Dialysis - Products - Acute Dialysis Products Need more information about Report Methodology? Click here- https://www.factmr.com/connectus ...
8/13/2021 ICU Medical (NASDAQ:ICUI) Downgraded by Zacks Investment Research ICU Medical (NASDAQ:ICUI) was downgraded by Zacks Investment Research from a ‚Auhold‚Au rating to a ‚Ausell‚Au rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, ‚AuICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world‚Aos leading pure-play infusion therapy companies, with global operations and a wide ...
8/12/2021 ICU Medical (NASDAQ:ICUI) Downgraded to ‚ÄúSell‚Äù at Zacks Investment Research Zacks Investment Research cut shares of ICU Medical (NASDAQ:ICUI) from a hold rating to a sell rating in a research report sent to investors on Wednesday morning, Zacks.com reports. According to Zacks, ‚AuICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world‚Aos leading pure-play infusion therapy companies, with global operations and a ...
8/12/2021 Zacks Investment Research Downgrades ICU Medical (NASDAQ:ICUI) to Sell Zacks Investment Research lowered shares of ICU Medical (NASDAQ:ICUI) from a hold rating to a sell rating in a report issued on Wednesday morning, Zacks.com reports. According to Zacks, ‚AuICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world‚Aos leading pure-play infusion therapy companies, with global operations and a wide-ranging product ...
5/13/2021 Comparing Integer (NYSE:ITGR) & Axion Power International (OTCMKTS:AXPWQ) ... oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and ...
5/13/2021 Head to Head Analysis: Integer (NYSE:ITGR) vs. Axion Power International (OTCMKTS:AXPWQ) ... oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and ...
5/9/2021 Reviewing Integer (NYSE:ITGR) and Axion Power International (OTCMKTS:AXPWQ) ... oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and ...
5/7/2021 Head to Head Review: Integer (NYSE:ITGR) versus Byrna Technologies (OTCMKTS:BYRN) Mayfield Recorder ... oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and ...
3/24/2021 Global Home Infusion Therapy Market Report 2021: Growth, Trends, COVID-19 Impact, and Forecasts to 2026 ‚Äì ResearchAndMarkets.com | Financial Buzz The ‚AuHome Infusion Therapy Market ‚Ai Growth, Trends, COVID-19 Impact, and Forecasts (2021 ‚Ai 2026)‚Au report has been added to ResearchAndMarkets.com‚Aos offering.The home infusion therapy market was valued at USD 20,976 ... supporting patients. In April 2020, the American Society of Clinical Oncology (ASCO) issued guidelines for the infusion therapies for hospital and home infusion services, in order to ensure the safety of patients.The American Society ...
3/23/2021 Global Home Infusion Therapy Market Report 2021: Growth, Trends, COVID-19 Impact, and Forecasts to 2026 - ResearchAndMarkets.com Yahoo News The "Home Infusion Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.The home infusion therapy market was valued at USD 20,976 million in 2020 and ... supporting patients. In April 2020, the American Society of Clinical Oncology (ASCO) issued guidelines for the infusion therapies for hospital and home infusion services, in order to ensure the safety of patients.The American Society ...
3/23/2021 Global Home Infusion Therapy Market Report 2021: Growth, Trends, COVID-19 Impact, and Forecasts to 2026 - ResearchAndMarkets.com | Business Wire Business Wire DUBLIN--( BUSINESS WIRE )--The "Home Infusion Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.The home infusion therapy market was valued at USD 20,976 million ... supporting patients. In April 2020, the American Society of Clinical Oncology (ASCO) issued guidelines for the infusion therapies for hospital and home infusion services, in order to ensure the safety of patients.The American Society ...
3/23/2021 The Ridgway Record The "Home Infusion Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.The home infusion therapy market was valued at USD 20,976 million in 2020 and ... supporting patients. In April 2020, the American Society of Clinical Oncology (ASCO) issued guidelines for the infusion therapies for hospital and home infusion services, in order to ensure the safety of patients.The American Society ...
3/23/2021 The "Home Infusion Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.The home infusion therapy market was valued at USD 20,976 million in 2020 and ... supporting patients. In April 2020, the American Society of Clinical Oncology (ASCO) issued guidelines for the infusion therapies for hospital and home infusion services, in order to ensure the safety of patients.The American Society ...
3/23/2021 Circulating Hybrid Cells May Help to Monitor Treatment Response in Patients With Rectal and Esophageal Cancers ... Oncology 2021 International Conference on Surgical Cancer Care ( Poster 21 ).Real-time monitoring of treatment response with a liquid biomarker may help to inform treatment decisions in patients undergoing neoadjuvant therapies for rectal and esophageal cancers, as well as in patients with metastatic colorectal cancer receiving hepatic arterial infusion therapy.More About Circulating Hybrid CellsCirculating hybrid cells are immune-tumor cell fusion hybrids detectable in the peripheral blood of ...
3/16/2021 IMPACT Strategies completes ambulatory surgery center ... infusion therapy, radiation oncology, a LINAC (Linear Accelerator) suite, a CT scan suite, an X-ray suite, clinical research, and other cancer support services.More than 70,000 square-feet of the vacant store was repurposed to create space for the two healthcare specialties. In addition to life-saving equipment, the facility also includes medical office space, waiting rooms, a new elevator, and a pharmacy.IMPACT Strategies was hired by Cullinan ...
2/10/2021 Integer (NYSE:ITGR) and AER Energy Resources (OTCMKTS:AERN) Head-To-Head Contrast N/ASummaryInteger beats AER Energy Resources on 8 of the 9 factors compared between the two stocks.Integer Company ProfileInteger Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also ...
1/12/2021 CVS Health Partners with National Oncology Network to Offer In-Home Chemotherapy Home Health Care News ... infusion therapy services ‚Ai as well as CTCA‚Aos experience as a top oncology care provider.The main goal of the pilot is to keep immunocompromised patients away from the COVID-19 virus. But it could also lay the groundwork for future cancer care in the home. AdvertisementAlthough it will begin solely in Atlanta, the program is set to expand geographically over ‚Authe next few months.‚Au‚AuThe program ...
1/8/2021 Intermountain Heber Valley Hospital Launches TeleHealth Oncology Services to Enable Cancer Patients to Be Treated Closer to Home Intermountain Heber Valley Hospital Launches TeleHealth Oncology Services to Enable Cancer Patients to Be Treated Closer to HomeHeber City, UT -- ( ReleaseWire ) -- 01/08/2021 --Intermountain Heber Valley Hospital recently began offering Intermountain TeleHealth oncology services to ... and staffed with dedicated nurses trained to do chemotherapy and infusion therapy," said Chad Marsing, Heber Valley Infusion and Pharmacy Manager. "It's a whole new way of serving our community. Our expanded tele-oncology services ...
1/8/2021 The Ridgway Record Heber City, UT 01/08/2021 -- Intermountain Heber Valley Hospital recently began offering Intermountain TeleHealth oncology services to local patients, including onsite chemotherapy treatments and consultations with Intermountain Healthcare's team of oncologists and cancer experts from Intermountain ... and staffed with dedicated nurses trained to do chemotherapy and infusion therapy," said Chad Marsing, Heber Valley Infusion and Pharmacy Manager. "It's a whole new way of serving our community. Our expanded tele-oncology services ...
8/16/2020 ICU Medical (NASDAQ:ICUI) Stock Rating Upgraded by Zacks Investment Research - Ticker Report Ticker Report ... oncology and critical care applications. They are one of the world’s leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow ...
6/16/2020 Weekly Analysts’ Ratings Updates for ICU Medical (ICUI) - American Banking News American Banking News ... oncology and critical care applications. They are one of the world’s leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow ...